Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | AFM13 |
Trade Name | |
Synonyms | |
Drug Descriptions |
AFM13 is a bispecific antibody against human CD30 and CD16A, which cross-links tumor cells and NK cells, resulting in anti-tumor immune response (PMID: 26231785). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C94219 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AFM13 | AFM13 | 0 | 3 |
AFM13 + Cyclophosphamide + Fludarabine | AFM13 Cyclophosphamide Fludarabine | 0 | 0 |
AFM13 + Pembrolizumab | AFM13 Pembrolizumab | 0 | 1 |